This record was last updated April 21, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The trial aims to collect safety, efficacy, exposure, dose- response, pharmacokinetic and pharmacodynamic information of the combination of L19TNF and lomustine at different dose levels in patients with Glioblastoma at progression or recurrence
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-21; most recent amendment 2026-04-16.
Status change: Recruiting → Active, Not Recruiting2026-04-16
Status change: Not Yet Recruiting → Recruiting2025-01-21